Report Detail

Pharma & Healthcare Global Metabotropic Glutamate Receptor 5 Sales Market Report 2019

  • RnM2791959
  • |
  • 22 January, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Metabotropic Glutamate Receptor 5 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Metabotropic Glutamate Receptor 5 market status and forecast, categorizes the global Metabotropic Glutamate Receptor 5 market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others

Segment by Application
Major Depressive Disorder
Alcohol Assiction
Alzheimer's Disease
Others


Table of Contents

    Global Metabotropic Glutamate Receptor 5 Sales Market Report 2019

      1 Metabotropic Glutamate Receptor 5 Market Overview

      • 1.1 Metabotropic Glutamate Receptor 5Product Overview
      • 1.2 Metabotropic Glutamate Receptor 5 Segment by Type
        • 1.2.1 Global Metabotropic Glutamate Receptor 5 Sales Comparison by Types (2014-2025)
        • 1.2.2 Alloswitch-1
        • 1.2.3 BMS-952048
        • 1.2.4 BMS-955829
        • 1.2.5 Dipraglurant ER
        • 1.2.6 Others
      • 1.3 Metabotropic Glutamate Receptor 5 Segment by Application
        • 1.3.1 Global Metabotropic Glutamate Receptor 5 Sales Comparison by Application (2014-2025)
        • 1.3.1 Major Depressive Disorder
        • 1.3.2 Alcohol Assiction
        • 1.3.3 Alzheimer's Disease
        • 1.3.4 Others
      • 1.4 Metabotropic Glutamate Receptor 5 Market by Region
        • 1.4.1 Global Metabotropic Glutamate Receptor 5 Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
        • 1.4.3 Europe Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
        • 1.4.4 China Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
        • 1.4.5 Japan Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
        • 1.4.7 India Metabotropic Glutamate Receptor 5 Status and Prospect (2014-2025)
      • 1.5 Global Metabotropic Glutamate Receptor 5 Sales and Revenue (2014-2025)
        • 1.5.1 Global Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2014-2025)
        • 1.5.2 Global Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2014-2025)

      2 Metabotropic Glutamate Receptor 5 by Company, Region, Type and Application

      • 2.1 Global Metabotropic Glutamate Receptor 5 Market Competition by Companies
        • 2.1.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2014-2019)
      • 2.2 Global Metabotropic Glutamate Receptor 5 Sales and Revenue by Region
        • 2.2.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2014-2019)
        • 2.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2014-2019)
      • 2.3 Global Metabotropic Glutamate Receptor 5 Sales and Revenue by Type
        • 2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2014-2019)
        • 2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2014-2019)
      • 2.4 Global Metabotropic Glutamate Receptor 5 Sales by Application

      3 United States Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 3.1 United States Metabotropic Glutamate Receptor 5 Sales and Revenue (2014-2019)
        • 3.1.1 United States Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 3.1.2 United States Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 3.1.3 United States Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 3.2 United States Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 3.3 United States Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 3.4 United States Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      4 Europe Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 4.1 Europe Metabotropic Glutamate Receptor 5 Sales and Value (2014-2019)
        • 4.1.1 Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 4.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 4.2 Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 4.3 Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 4.4 Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      5 China Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 5.1 China Metabotropic Glutamate Receptor 5 Sales and Revenue (2014-2019)
        • 5.1.1 China Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 5.1.2 China Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 5.1.3 China Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 5.2 China Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 5.3 China Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 5.4 China Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      6 Japan Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 6.1 Japan Metabotropic Glutamate Receptor 5 Sales and Value (2014-2019)
        • 6.1.1 Japan Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 6.1.2 Japan Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 6.2 Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 6.3 Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 6.4 Japan Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      7 Southeast Asia Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 7.1 Southeast Asia Metabotropic Glutamate Receptor 5 Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 7.2 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 7.3 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 7.4 Southeast Asia Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      8 India Metabotropic Glutamate Receptor 5 Sales, Revenue and Price

      • 8.1 India Metabotropic Glutamate Receptor 5 Sales and Value (2014-2019)
        • 8.1.1 India Metabotropic Glutamate Receptor 5 Sales Growth Rate (2014-2019)
        • 8.1.2 India Metabotropic Glutamate Receptor 5 Revenue Growth Rate (2014-2019)
        • 8.1.3 India Metabotropic Glutamate Receptor 5 Price Trend (2014-2019)
      • 8.2 India Metabotropic Glutamate Receptor 5 Sales Market Share by Company
      • 8.3 India Metabotropic Glutamate Receptor 5 Sales Market Share by Type
      • 8.4 India Metabotropic Glutamate Receptor 5 Sales Market Share by Application

      9 Company Profiles and Key Figures in Metabotropic Glutamate Receptor 5 Business

      • 9.1 Addex Therapeutics Ltd
        • 9.1.1 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.1.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 Aevi Genomic Medicine Inc
        • 9.2.1 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.2.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 Bristol-Myers Squibb Company
        • 9.3.1 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.3.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Eisai Co Ltd
        • 9.4.1 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.4.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 Eli Lilly and Company
        • 9.5.1 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.5.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Heptares Therapeutics Ltd
        • 9.6.1 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.6.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Johnson & Johnson
        • 9.7.1 Johnson & Johnson Production Sites and Area Served
        • 9.7.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 Merz Pharma GmbH & Co KgaA
        • 9.8.1 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.8.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 Novartis AG
        • 9.9.1 Novartis AG Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.9.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Richter Gedeon Nyrt
        • 9.10.1 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Production Sites and Area Served
        • 9.10.2 Metabotropic Glutamate Receptor 5 Specification and Application
        • 9.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 Sumitomo Dainippon Pharma Co Ltd
      • 9.12 Toray Industries Inc

      10 Metabotropic Glutamate Receptor 5 Maufacturing Cost Analysis

      • 10.1 Metabotropic Glutamate Receptor 5 Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5
      • 10.4 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 Metabotropic Glutamate Receptor 5 Distributors List
      • 11.3 Metabotropic Glutamate Receptor 5 Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 Metabotropic Glutamate Receptor 5 Market Forecast

      • 13.1 Global Metabotropic Glutamate Receptor 5 Sales, Revenue and Price Forecast
        • 13.1.1 Global Metabotropic Glutamate Receptor 5 Sales Growth Forecast (2019-2025)
        • 13.1.2 Global Metabotropic Glutamate Receptor 5 Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global Metabotropic Glutamate Receptor 5 Price Trend Forecast (2019-2025)
      • 13.2 Global Metabotropic Glutamate Receptor 5 Forecast by Region
        • 13.2.1 Global Metabotropic Glutamate Receptor 5 Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India Metabotropic Glutamate Receptor 5 Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global Metabotropic Glutamate Receptor 5 Forecast by Type
        • 13.3.1 Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2019-2025)
        • 13.3.2 Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2019-2025)
      • 13.4 Global Metabotropic Glutamate Receptor 5 Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        Summary:
        Get latest Market Research Reports on Metabotropic Glutamate Receptor 5. Industry analysis & Market Report on Metabotropic Glutamate Receptor 5 is a syndicated market report, published as Global Metabotropic Glutamate Receptor 5 Sales Market Report 2019. It is complete Research Study and Industry Analysis of Metabotropic Glutamate Receptor 5 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,000.00
        $6,000.00
        $8,000.00
        3,156.00
        4,734.00
        6,312.00
        3,736.00
        5,604.00
        7,472.00
        629,920.00
        944,880.00
        1,259,840.00
        334,320.00
        501,480.00
        668,640.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report